A post-hoc analysis of the pivotal CANVAS trial shows those receiving higher dose canagliflozin are more likely to experience the cardiovascular benefits associated with the drug.

A cheap over-the-counter supplement could hold the key to preventing heart failure in people with Type 2 diabetes, according ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

The researchers discovered that after just six months of use, patients had double the risk of developing neovascular ...